Source: Annual Congress 2012 - Management of severe respiratory infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Miller, H. Tedd, S. Syba, H. Groves, A. De Soyza (Newcastle-upon-Tyne, United Kingdom). Tolerance of nebulised gentamicin in adult bronchiectasis – A single centre study. Eur Respir J 2012; 40: Suppl. 56, 2456

Member's Comments

No comment yet.

Related content which might interest you: Distribution of nebulised gentamicin in patients with bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004 Evaluation of difficult asthma – a single centre experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Treatment of patients with uncontrolled asthma using high dose inhaled corticosteroids administered by controlled inhalation – a retrospective analysis Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Antimicrobial properties of aerosolized liposomal cyclosporine (L-CsA) in lung transplantation patients – An in vitro study Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 A placebo-controlled study of liposomal amikacin for inhalation nebulized once daily in the treatment of bronchiectasis patients with chronic pseudomonas aeruginosa lung infection Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009 Adherence with inhaled colistimethate sodium during a 6 month study in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Heliox administration in patients with COPD exacerbation – Technical aspects Source: Annual Congress 2010 - Mechanical ventilation and weaning Year: 2010 Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Tolerance of pirfenidone in Indian patients with idiopathic pulmonary fibrosis – Usual interstial pneumonitis: An initial experience Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Effectiveness of fixed ICS/LABA combinations in COPD – A population based register linkage study Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system] Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Overdiagnosis of severe asthma – single centre study. Preliminary results Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Antibiotic treatment strategies in adults with bronchiectasis Source: Eur Respir Mon 2011; 52: 211-222 Year: 2011 Efficacy of inhaled dry powder tobramycin (TOBI Podhaler) in P. aeruginosa infected patients with bronchiectasis - iBEST study Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy Year: 2020 Treatment of sarcoidosis – pentoxifylline Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Inhaled liposomal ciprofloxacin hydrochloride significantly reduces sputum pseudomonas aeruginosa density in non-CF bronchiectasis Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009 Single dose pharmacokinetics of C16TR for Inhalation (INS1009) vs treprostinil inhalation solution Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Effectiveness and adherence to treatment with nebulized colistimethate sodium (Promixin®) in non-cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa (PsA) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum pseudomonas aeruginosa (Pa) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE) Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011 Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016